Canadian Business  Aug 16  Comment 
VANCOUVER - Pharmachem Laboratories Inc. has increased its offer for the assets of Forbes Medi-Tech Inc., a Vancouver-area drug developer that is
Canadian Business  Jul 20  Comment 
VANCOUVER - Forbes Medi-Tech Inc. (OTCBB:FMTI) said Tuesday it has received a takeover approach from Pharmachem Laboratories Inc., a New
Canadian Business  Jul 13  Comment 
VANCOUVER - Most of the business assets of Forbes Medi-Tech Inc. (OTCBB:FMTI), a Canadian drug research and development company that's winding up
Canadian Business  May 10  Comment 
VANCOUVER - Biotechnology company Forbes Medi-Tech Inc. reported a small first-quarter loss Monday as it continued its search for a
Marketwire  Feb 17  Comment 
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/17/10 -- Forbes Medi-Tech Inc. (NASDAQ: FMTI) ("Forbes" or "Company") announced that it received notification on February 16, 2010 that a NASDAQ Listing Qualifications Panel has determined to delist
Canadian Business  Jan 14  Comment 
VANCOUVER, B.C. - Forbes Medi-Tech Inc. (NASDAQ:FMTI) says it will appeal a delisting notice from the Nasdaq stock market, after being told that
StreetInsider.com  Jan 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Forbes+Medi-Tech+%28FMTI%29+Receives+Deficiency+Letter+from+NASDAQ%3B+Does+Not+Meet+Rule+5505/5233462.html for the full story.
Marketwire  Dec 7  Comment 
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/07/09 -- Forbes Medi-Tech Inc. (NASDAQ: FMTI) ("Forbes" or "Company") announced the launch of a new pineapple juice containing the Company's proprietary cholesterol-lowering ingredient, Reducol(TM) in
Marketwire  Nov 9  Comment 
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 11/09/09 -- Forbes Medi-Tech Inc. (NASDAQ: FMTI) ("Forbes" or "Company") today announced its results for the third quarter ended September 30, 2009. The comparative period for these statements is the
Marketwire  Oct 26  Comment 
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 10/26/09 -- Forbes Medi-Tech Inc. (NASDAQ: FMTI) ("Forbes" or "Company") today announced that the European Union ("EU") has approved a health claim for plant sterols in free or esterified form. This



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki